Crafting a system-wide response to healthcare-associated infections

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 17, 2012, Pages 6364-6365

  Laxminarayan, Ramanan ^a,b,c  

^a Center for Disease Dynamics Economics and Policy   (United States)

^b PRINCETON UNIVERSITY   (United States)

^c PUBLIC HEALTH FOUNDATION OF INDIA   (India)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDEMIC; HEALTH CARE PERSONNEL; HOSPITAL COST; HOSPITAL INFECTION; HUMAN; LENGTH OF STAY; MEDICARE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MORTALITY; NOTE; PRIORITY JOURNAL; VANCOMYCIN RESISTANT ENTEROCOCCUS;

GENETICS, POPULATION; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCAL INFECTIONS;

EID: 84860197790     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1203676109     Document Type: Note

References (13)

1. Eber MR, Laxminarayan R, Perencevich EN, Malani A (2010) Clinical and economic outcomes attributable to health care-associated sepsis and pneumonia. Arch Intern Med 170:347-353.
2. Klevens RM, et al.; Active Bacterial Core surveillance (ABCs) MRSA Investigators (2007) Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298:1763-1771. (Pubitemid 47598444)
3. Cosgrove SE, et al. (2005) The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: Mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol 26:166-174. (Pubitemid 40445022)
4. Engemann JJ, et al. (2003) Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis 36(5):592-598. (Pubitemid 36259564)
5. PHC4 (2005) Reducing hospital-acquired infections: The business case. Research Brief No. 8 (Pennsylvania Health Care Cost Containment Council), Available at http://www.phc4.org/reports/researchbriefs/111705/docs/ researchbrief2005report-hospacqinfections-bizcase.pdf. Accessed March 18, 2012.
6. Ke W, et al. (2012) Patient sharing and population genetic structure of methicillin-resistant Staphylococcus aureus. Proc Natl Acad Sci USA 109:6763-6768.
7. Smith DL, Levin SA, Laxminarayan R (2005) Strategic interactions in multi-institutional epidemics of antibiotic resistance. Proc Natl Acad Sci USA 102:3153-3158. (Pubitemid 40299931)
8. European Centre for Disease Prevention and Control (2012) Surveillance of Healthcare-Associated Infections in Europe 2007 (ECDC, Stockholm).
9. Dutch Working Party for Infection Prevention (2005) Policy for Methicillin-Resistant Staphylococcus aureus. Available at http://www.wip.nl. Accessed March 30, 2012.
10. Vriens M, et al. (2002) Costs associated with a strict policy to eradicate methicillin-resistant Staphylococcus aureus in a Dutch University Medical Center: A 10-year survey. Eur J Clin Microbiol Infect Dis 21:782-786. (Pubitemid 35435699)
11. Ostrowsky BE, et al. (2001) Control of vancomycin-resistant enterococcus in health care facilities in a region. N Engl J Med 344:1427-1433. (Pubitemid 32402099)
12. Muto CA, et al.; Society for Healthcare Epidemiology of America (2003) SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus. Infect Control Hosp Epidemiol 24:362-386. (Pubitemid 36612323)
13. Lee BY, et al. (2011) Long-term care facilities: Important participants of the acute care facility social network? PLoS ONE 6:e29342.